Synthesis and cytotoxicity of the conjugates of diterpenoid isosteviol and -acetyl-D-glucosamine.

Clicks: 337
ID: 81116
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #18 of 83 articles by views in Natural product research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A series of conjugates of diterpenoid isosteviol (16-oxo--beyeran-19-oic acid) and -acetyl-D-glucosamine was synthesised and their cytotoxicity against several human cancer cell lines (M-Hela, MCF-7, Hep G2, Panc-1, PC-3), as well as normal human cell lines (WI-38, Chang liver) was assayed. Most of the conjugates were found to be cytotoxic against the mentioned cancer cell lines in the range of IC values 13-89 µM. Two lead compounds and showed selective cytotoxicity against M-Hela (IC 13 and 14 µM) that was two times as high as the cytotoxicity of the anti-cancer drug Tamoxifen in control (IC 28 µM). It was found that cytotoxic activity of the lead compounds against M-Hela cells is due to induction of apoptosis.
Reference Key
garifullin2019synthesisnatural Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Garifullin, Bulat F;Strobykina, Irina Yu;Khabibulina, Leysan R;Sapunova, Anastasiya S;Voloshina, Aleksandra D;Sharipova, Radmila R;Khairutdinov, Bulat I;Zuev, Yuriy F;Kataev, Vladimir E;
Journal Natural product research
Year 2019
DOI
10.1080/14786419.2019.1650355
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.